1D·

Hims & Hers: Statement on the insider sale of the CEO

As was announced yesterday, the CEO of $HIMS (+0,21%) Novo Nordisk sold his largest block of shares to date one day after the wave of lawsuits filed by Novo Nordisk last week, and not via the 10b5-1 regulation.

The day before yesterday he was still encouraging shareholders to buy the $HIMS (+0,21%) to buy the stock.

Now there was the following statement:

Despite his sale, he still owns a >10% position in the company.

How do you assess this? Can the CEO still be trusted or is this a no-go that casts doubt on his integrity?

4 Comentários

Zottel@Zottel4Profit

I am very optimistic in the long term. So far, Hims' management has always communicated authentically and honestly with investors. How do you see it personally?

•

The W.@thewolfofallstreetz

@Zottel4Profit I have a good impression of him and have no problem with the CEO selling shares. But I don't like the context in which this is happening. The last quarterly figures were poor, the outlook for 2025 is no better and the legal risk has increased again after the end of the partnership - the valuation is also no longer in bargain territory, so the risk/reward is no longer as attractive as it was 12-18 months ago. However, if they continue to execute, it is an interesting share in the long term.

•

Zottel@Zottel4Profit

@thewolfofallstreetz Right, that's a good point. Let's see what happens in the future...

••

N@Khlmysee

All criminals...

••